Protective cellular immunity against a spontaneous mammary carcinoma from ras transgenic mice (Q41464758)

1 October 2017

title

Protective cellular immunity against a spontaneous mammary carcinoma from ras transgenic mice (English)

1 reference

1 October 2017

Heike M

1

1 reference

1 October 2017

Blachere NE

series ordinal

2

1 reference

1 October 2017

Srivastava PK

series ordinal

3

1 reference

1 October 2017

publication date

1 June 1994

1 reference

1 October 2017

1 reference

1 October 2017

volume

190

1 reference

1 October 2017

issue

4-5

1 reference

1 October 2017

page(s)

411-423

1 reference

Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Antigenicity of murine skin tumors induced by ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

The effect of thymectomy and of the dose of 3-methylcholanthrene on the induction and antigenic properties of sarcomas in C56Bl mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Surveillance, latency and the two levels of MCA-induced tumor immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980612-1

7 January 2021

10.1016/S0171-2985(11)80612-1

Identifiers

DOI

0 references

1 reference